Heritable methylation marks associated with breast and prostate cancer risk-Reference-Cited by-同舟云学术

Heritable methylation marks associated with breast and prostate cancer risk

Published:2018-05-29 Issue:13 Volume:78 Page:962-969
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Dugué Pierre-Antoine¹²,Dowty James G.²,Joo Jihoon E.³,Wong Ee M.³⁴,Makalic Enes²,Schmidt Daniel F.²⁵,English Dallas R.¹²,Hopper John L.²,Pedersen John⁶,Severi Gianluca¹²⁷,MacInnis Robert J.¹²,Milne Roger L.¹²⁴,Giles Graham G.¹²,Southey Melissa C.³⁴^ORCID

Affiliation:

1. Cancer Epidemiology and Intelligence Division; Cancer Council Victoria; Victoria Australia

2. Centre for Epidmiology and Biostatistics; Melbourne School of Population and Global Health; The University of Melbourne; Victoria Australia

3. Genetic Epidemiology Laboratory; Department of Clinical Pathology; The University of Melbourne; Victoria Australia

4. Precision Medicine; School of Clinical Sciences at Monash Health; Monash University; Clayton Victoria Australia

5. Faculty of Information Technology; Monash University; Victoria Australia

6. TissuPath; Mount Waverley; Australia

7. Centre de Recherche en Épidémiologie et Santé des Populations (CESP, Inserm U1018); Université Paris-Saclay, UPS, UVSQ; Gustave Roussy; Villejuif France

Funder

National Health and Medical Research Council

Cancer Council Victoria

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.23654/fullpdf

Reference42 articles.

1. The contribution of rare variation to prostate cancer heritability;Mancuso;Nat Genet,2016

2. Germline mutations in HOXB13 and prostate-cancer risk;Ewing;N Eng J Med,2012